Pepgen Inc. (PEPG) — 8-K Filings

8-K Filings (26)

• 8-K Filing — Dec 8, 2025
• PepGen Announces Executive and Board Changes — Nov 7, 2025 Risk: medium
  PepGen Inc. announced on November 4, 2025, a series of executive and board changes. These include the appointment of Dr. James R. Muldoon as Chief Medical Offic
• PepGen Inc. Files 8-K: Regulation FD & Exhibits — Oct 1, 2025 Risk: low
  PepGen Inc. filed an 8-K on October 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Delaware w
• PepGen Inc. Files 8-K: Material Definitive Agreement — Sep 26, 2025 Risk: medium
  On September 24, 2025, PepGen Inc. entered into a material definitive agreement. The filing also notes other events and includes financial statements and exhibi
• PepGen Inc. Files 8-K for Standard Disclosures — Sep 24, 2025 Risk: low
  PepGen Inc. filed an 8-K on September 24, 2025, reporting on other events and financial statements. The filing does not contain specific details about new mater
• PepGen Inc. Reports on Security Holder Vote — Jun 6, 2025 Risk: medium
  PepGen Inc. filed an 8-K on June 6, 2025, reporting on a matter submitted to a vote of its security holders. The filing indicates an event occurred on June 4, 2
• PepGen Inc. Files 8-K with Regulatory Updates — May 28, 2025 Risk: low
  PepGen Inc. filed an 8-K on May 28, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Fi
• PepGen Appoints Dr. Michael J. Yauch as Chief Medical Officer — Mar 31, 2025 Risk: low
  PepGen Inc. announced on March 31, 2025, that its Board of Directors appointed Dr. Michael J. Yauch as Chief Medical Officer, effective March 27, 2025. Dr. Yauc
• PepGen Appoints New Director — Mar 28, 2025 Risk: low
  PepGen Inc. announced on March 28, 2025, that its Board of Directors appointed Dr. Michael J. Yaszemski as a new director, effective March 24, 2025. Dr. Yaszems
• PepGen Inc. Files 8-K Report — Mar 4, 2025 Risk: low
  PepGen Inc. filed an 8-K on March 4, 2025, to report other events and financial statements. The company, incorporated in Delaware with its principal executive o
• PepGen Inc. Files 8-K with Financial Statements — Jan 29, 2025 Risk: low
  On January 29, 2025, PepGen Inc. filed an 8-K report. The filing primarily concerns the submission of financial statements and exhibits, with no other specific
• PepGen Inc. Files 8-K: Other Events & Financials — Dec 16, 2024 Risk: low
  PepGen Inc. filed an 8-K on December 16, 2024, reporting other events and financial statements. The company, incorporated in Delaware with its principal executi
• PepGen Inc. Files 8-K with Financials and Exhibits — Oct 8, 2024 Risk: low
  On October 8, 2024, PepGen Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other
• PepGen Appoints New CEO, Dr. Michael Yaszemski — Sep 19, 2024 Risk: medium
  PepGen Inc. announced on September 19, 2024, that its Board of Directors has appointed Dr. Michael J. Yaszemski as Chief Executive Officer and a member of the B
• PepGen Inc. Files 8-K with SEC — Aug 20, 2024 Risk: low
  PepGen Inc. filed an 8-K on August 20, 2024, to report other events and financial statements. The filing does not detail specific transactions or financial resu
• EQT X to Acquire PepGen for $1.4 Billion — Jul 30, 2024 Risk: medium
  PepGen Inc. announced on July 30, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of EQT X, a leading global investment org
• PepGen Inc. Files 8-K Report — Jul 2, 2024 Risk: low
  On July 2, 2024, PepGen Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no other specific events detailed in the
• PepGen Inc. Files 8-K with Corporate Updates — Jun 20, 2024 Risk: low
  PepGen Inc. filed an 8-K on June 20, 2024, reporting on several key corporate events. The filing indicates changes to its articles of incorporation or bylaws, s
• PepGen Inc. Files 8-K Report — Jun 11, 2024 Risk: low
  On June 11, 2024, PepGen Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or d
• PepGen Relocates Principal Executive Offices — Mar 15, 2024 Risk: low
  PepGen Inc. filed an 8-K on March 15, 2024, reporting a change in its principal executive offices to 321 Harrison Avenue, 8th Floor, Boston, Massachusetts 02118
• PepGen Inc. Files 8-K Report — Mar 13, 2024 Risk: low
  On March 13, 2024, PepGen Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no other specific events detailed in t
• PepGen Inc. Files 8-K Report — Mar 4, 2024 Risk: low
  On March 4, 2024, PepGen Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other si
• PepGen Inc. Files 8-K for Other Events and Exhibits — Feb 20, 2024 Risk: low
  PepGen Inc. filed an 8-K on February 20, 2024, reporting 'Other Events' and 'Financial Statements and Exhibits'. The company, incorporated in Delaware with IRS
• PepGen Files 8-K on Material Definitive Agreement; Details Pending — Feb 7, 2024
  This 8-K filing from PepGen Inc. on February 7, 2024, reports an "Entry into a Material Definitive Agreement" and "Other Events" that occurred on February 6, 20
• PepGen Inc. Updates Principal Executive Office Address — Jan 17, 2024
  PepGen Inc. filed an 8-K on January 17, 2024, to update its principal executive offices from 1 Marina Park Drive, Suite 900, Boston, MA 02210 to 321 Harrison Av
• PepGen Inc. Relocates Principal Executive Offices in Boston — Jan 8, 2024
  PepGen Inc. filed an 8-K on January 8, 2024, to update its principal executive offices from 1 Marina Park Drive, Suite 900, Boston, MA 02210 to 321 Harrison Ave

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX